Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
9920
Description
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Keywords
Versions (5)
- 3/4/15 3/4/15 -
- 3/9/15 3/9/15 -
- 4/22/15 4/22/15 -
- 12/8/15 12/8/15 -
- 2/11/16 2/11/16 -
Uploaded on
March 4, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
CL Item
Induction I (1)
CL Item
Induction II (optional) (2)
CL Item
Consolidation I (3)
CL Item
Consolidation II (4)
CL Item
Consolidation III (5)
CL Item
Consolidation IV (6)
CL Item
Maintenance (7)
CL Item
Follow-up (8)
CL Item
after 3 Months (3)
CL Item
after 6 Months (6)
CL Item
after 9 Months (9)
CL Item
after 12 Months (12)
Follow up number
Item
If Follow-up: consecutive Follow-up number
integer
C1704685 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
C0237753 (UMLS CUI-2)
Status of patient
Item
Is the patient alive?
boolean
C3844896 (UMLS CUI-1)
Date of last information/death
Item
Date of last information/death
date
C1148348 (UMLS CUI-1)
C0011008 (UMLS CUI-2)
C1533716 (UMLS CUI-3)
C0011008 (UMLS CUI-2)
C1533716 (UMLS CUI-3)
CL Item
Leukemia (1)
CL Item
Infection (2)
CL Item
Bleeding (3)
CL Item
Secondary illness (4)
CL Item
Other (5)
CL Item
Unknown (6)
Specifiy if Cause of death = 2,4,5
Item
Specifiy if Cause of death = 2,4,5
text
Item Group
Response after Induction Cycles or Consolidation or Maintenance or during Follow-up
Date of evaluation
Item
Date of evaluation
date
C0220825 (UMLS CUI-1)
C0011008 (UMLS CUI-2)
C0011008 (UMLS CUI-2)
CL Item
CR (1)
CL Item
CRi (2)
CL Item
PR (3)
CL Item
RD (4)
CL Item
PD (5)
CL Item
ED (6)
CL Item
HD (7)
Extramedullary Manifestatation
Item
Extramedullary Manifestatation
boolean
C1517060 (UMLS CUI-1)
C1280464 (UMLS CUI-2)
C1280464 (UMLS CUI-2)
Extramedullary Manifestatation location
Item
Please specify Extramedullary Manifestation
text
Item Group
Evaluation based on on following examinations
Bone marrow evaluation done
Item
Bone marrow evaluation done (If yes specify on CRF "Bone marrow Evaluation"
boolean
C2238269 (UMLS CUI-1)
C1272695 (UMLS CUI-2)
C1272695 (UMLS CUI-2)
Blood count evaluation done
Item
Blood count evaluation done? (If yes specify on CRF "Blood Count Evaluation"
boolean
C0005771 (UMLS CUI-1)
C0022885 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C1272695 (UMLS CUI-4)
C0022885 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C1272695 (UMLS CUI-4)
Date
Item
Date
date
C2346576 (UMLS CUI-1)
C0011008 (UMLS CUI-2)
C0011008 (UMLS CUI-2)
Name and Signature of Investigator
Item
Name and Signature of Investigator
text
C0027365 (UMLS CUI-1)
C1519316 (UMLS CUI-2)
C0031831 (UMLS CUI-3)
C1519316 (UMLS CUI-2)
C0031831 (UMLS CUI-3)